glp 1 ra meds GLP-1 Medications and Rheumatoid Arthritis: What the 2025 Research Actually Shows Indications for GLP-1/GIP RA Summary

When Combination Therapy May Be Considered Dual GLP-1 and DPP-4 therapy is typically considered when monotherapy with either agent achieves insufficient glycemic control

Palmieri A, Imbimbo C, Longo N et al: A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease

It also has powerful antibacterial and anti-inflammatory properties that can help combat acne and promote clearer skin

Electron microscopy studies reveal abnormal connective tissue stroma, thick basal lamina around ICC and myocytes, and large empty nerve endings suggest more profound conduction defects [44, 62] (Fig